Gene · 57733
GBA3: glucosylceramidase beta 3 (gene/pseudogene)
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GBA3: glucosylceramidase beta 3 (gene/pseudogene). Genes, record 57733. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/57733
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9H227 | Cytosolic beta-glucosidase | 469 | 5 | GeneID, HGNC |
Source UniProt
Patents10
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2025525334 A | 2025-08-05 | 371 | Q9H227 | Espacenet |
| WO 2025093745 A1 | 2025-05-08 | 175 | Q9H227 | Espacenet |
| WO 2025035031 A1 | 2025-02-13 | 52 | Q9H227 | Espacenet |
| JP 2023553904 A | 2023-12-26 | 968 | Q9H227 | Espacenet |
| US 9512448 B2 | 2016-12-06 | 45 | Q9H227 | Espacenet |
| US 8586006 B2 | 2013-11-19 | 15625 | Q9H227 | Espacenet |
| US 7740664 B2 | 2010-06-22 | 376 | Q9H227 | Espacenet |
| JP 2010500568 A | 2010-01-07 | 37096 | Q9H227 | Espacenet |
| EP 2057465 A2 | 2009-05-13 | 15625 | Q9H227 | Espacenet |
| WO 2008079406 A2 | 2008-07-03 | 376 | Q9H227 | Espacenet |
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,654
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GBA3 papers | Newest fiscal year |
|---|---|---|---|
| P30ES013508 | Center of Excellence in Environmental Toxicology | 9 | 2025 |
| R01AI118891 | Viral modulation of epitranscriptomic mechanisms | 9 | 2025 |
| R01CA160254 | Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach | 8 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30ES017885 | Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD) | 6 | 2025 |
| T32HG002760 | Institutional Training in the Genomic Sciences | 6 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 5 | 2025 |
| R01GM094231 | COMPUTATIONAL TOOLS FOR MASS SPECTROMETRY-BASED INTERACTOME DATA | 5 | 2025 |
| R01GM130091 | Quantitative Characterization of Glycopeptide Isomers | 5 | 2025 |
1 to 10 of 1,654Source NIH's project files
See all 1,654 nih grantsPapers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reliable luciferase immunoprecipitation system assays for the detection of porcine reproductive and respiratory syndrome virus antibodies. | Vet J | 2026 | 42365893 | PubTator, text mining | PubMed |
| Specificity profiling of SARS-CoV-2 PLpro using proteome-derived libraries of linear peptides suggests secondary preference for basic motifs. | Arch Biochem Biophys | 2026 | 42214738 | PubTator, text mining | PubMed |
| E50A Mutation Increases the Bioluminescence Activity of picALuc. | Biosensors (Basel) | 2026 | 41892059 | PubTator, text mining | PubMed |
| Recent Developments and Applications of Capillary and Microchip Electrophoresis in Proteomics and Peptidomics (2023-2025). | J Sep Sci | 2026 | 41877532 | PubTator, text mining | PubMed |
| Deciphering the STAT3-PXN positive feedback loop in GBM, IDH-wildtype: transcriptional regulation and inhibition of YB-1 ubiquitination. | Cell Death Discov | 2026 | 41872167 | PubTator, text mining | PubMed |
| A genus-wide interaction atlas across NS4B orthologues identifies a conserved role for UFMylation in orthoflavivirus replication. | Nat Commun | 2026 | 41826287 | PubTator, text mining | PubMed |
| Functional study of two flexible regions of the hepatitis E virus ORF1 replicase. | PLoS One | 2026 | 41805850 | PubTator, text mining | PubMed |
| Application of a novel myristoylproteomics approach identifies GLIPR2 as a key pro-ferroptotic substrate in non-small cell lung cancer. | Mater Today Bio | 2026 | 41782991 | PubTator, text mining | PubMed |
| Prolyl tRNA Synthetase Is Required for Mammarenavirus Multiplication. | Viruses | 2026 | 41754545 | PubTator, text mining | PubMed |
| Super-Resolution Imaging of Nuclear Pore Responses to Mechanical Stress and Energy Depletion. | Viruses | 2026 | 41754510 | PubTator, text mining | PubMed |
1 to 10 of 1,720
See all 1,720 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/57733
GET https://conductscience.org/api/genes/v1/57733/grants?page=2